- Article metrics
- Last updated: Thu, 29 Jan 2026 22:09:04 Z
Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells
Access & Citations
-
- 9987
- Article Accesses
-
- 127
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 31 tweeters
- 2 Facebook pages
- 15 news outlets
- 58 Mendeley
This article is in the 97th percentile (ranked 11,047th) of the 450,754 tracked articles of a similar age in all journals and the 66th percentile (ranked 16th) of the 48 tracked articles of a similar age in Nature Biomedical Engineering
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
News story from MedicalXpress on Monday 26 July 2021
MedicalXpress -
Exosome Formulation Developed to Deliver Antibodies for Choroidal Neovascularization Therapy
Chinese Academy of Sciences -
调节性T细胞外泌体智能递送VEGF抗体用于眼底新生血管性疾病研究获进展
Chinese Academy of Science -
中国学者Nature子刊发文:调节性T细胞外泌体
Ebiotrade
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.